School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
J Asthma. 2021 Sep;58(9):1229-1236. doi: 10.1080/02770903.2020.1776728. Epub 2020 Jun 18.
The Test of Adherence to Inhalers (TAI) is a validated self-reported questionnaire that can reliably assess adherence to inhalers through patient self-report. However, it was not available in Bahasa Melayu (BM) language, nor has it been validated for use in the Malaysian population. The study aimed, therefore, to translate the 10-item TAI questionnaire into BM and evaluate its psychometric properties.
The translation of the English version of the valid 10-item TAI questionnaire into BM was followed by subjecting it to a series of tests establishing factorial, concurrent and known group validities. Concurrent validity was assessed through Spearman's rank correlation coefficient against pharmacy refill-based adherence scores. Known group validity was assessed by cross-tabulation against asthma symptom control and using chi-square test. The internal consistency of the test scale was determined by a test-retest method using Cronbach's alpha (α) value and intraclass correlation coefficients.
A total of 120 adult asthma patients participated in the study. A 2-factor structure was obtained and confirmed with acceptable fit indices; CFI, NFI, IFI, TLI >0.9 and, RMSEA was 0.08. The reliability of the scale was 0.871. The test-retest reliability coefficient for the total sum score was 0.832 ( < 0.01), which indicated good reliability. The 10-item TAI-BM established concurrent and known group validities. The sensitivity and specificity of the tool were >85%.
The scale successfully translated into BM and validated. The 10-item TAI-BM appears fit for use in testing inhaler adherence of Malaysian patients with asthma.
吸入器依从性测试(TAI)是一种经过验证的自我报告问卷,通过患者自我报告可以可靠地评估吸入器的依从性。然而,它没有马来语(BM)版本,也没有在马来西亚人群中进行验证。因此,本研究旨在将 10 项 TAI 问卷翻译成 BM,并评估其心理测量特性。
将经过验证的 10 项 TAI 问卷的英文版本翻译成 BM,然后对其进行一系列测试,以确定其因子、同时和已知组的有效性。同时效度通过与基于药房补充的依从性评分的 Spearman 等级相关系数来评估。已知组的有效性通过与哮喘症状控制的交叉表和卡方检验来评估。使用 Cronbach 的 alpha(α)值和组内相关系数(ICC),通过测试-重测方法确定测试量表的内部一致性。
共有 120 名成年哮喘患者参与了这项研究。获得了一个 2 因素结构,并通过可接受的拟合指数进行了确认;CFI、NFI、IFI、TLI>0.9,RMSEA 为 0.08。该量表的可靠性为 0.871。总得分的测试-重测可靠性系数为 0.832(<0.01),表明可靠性良好。10 项 TAI-BM 建立了同时和已知组的有效性。该工具的灵敏度和特异性均>85%。
该量表成功地翻译成 BM 并得到验证。10 项 TAI-BM 似乎适合用于测试马来西亚哮喘患者的吸入器依从性。